López-Rubio Salvador, Chacon-Camacho Oscar F, Matsui Rodrigo, Guadarrama-Vallejo Dalia, Astiazarán Mirena C, Zenteno Juan C
Department of Retina, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Department of Genetics-Research Unit, Institute of Ophthalmology "Conde de Valenciana," Mexico City, Mexico.
Mol Vis. 2018 Feb 1;24:105-114. eCollection 2018.
To describe the retinal clinical features of a group of Mexican patients with Stargardt disease carrying the uncommon p.Ala1773Val founder mutation in .
Ten patients carrying the p.Ala1773Val mutation, nine of them homozygously, were included. Visual function studies included best-corrected visual acuity, electroretinography, Goldmann kinetic visual fields, and full-field electroretinography (ERG). In addition, imaging studies, such as optical coherence tomography (OCT), short-wave autofluorescence imaging, and quantitative analyses of hypofluorescence, were performed in each patient.
Best-corrected visual acuities ranged from 20/200 to 4/200. The median age of the patients at diagnosis was 23.3 years. The majority of the patients had photophobia and nyctalopia, and were classified as Fishman stage 4 (widespread choriocapillaris atrophy, resorption of flecks, and greatly reduced ERG amplitudes). An atypical retinal pigmentation pattern was observed in the patients, and the majority showed cone-rod dystrophy on full-field ERG. In vivo retinal microstructure assessment with OCT demonstrated central retinal thinning, variable loss of photoreceptors, and three different patterns of structural retinal degeneration. Two dissimilar patterns of abnormal autofluorescence were observed. No apparent age-related differences in the pattern of retinal degeneration were observed.
The results indicate that this particular mutation in is associated with a severe retinal phenotype and thus, could be classified as null. Careful phenotyping of patients carrying specific mutations in is essential to enhance our understanding of disease expression linked to particular mutations and the resulting genotype-phenotype correlations.
描述一组携带罕见的p.Ala1773Val始祖突变的墨西哥斯塔加特病患者的视网膜临床特征。
纳入10例携带p.Ala1773Val突变的患者,其中9例为纯合子。视觉功能研究包括最佳矫正视力、视网膜电图、戈德曼动态视野检查和全视野视网膜电图(ERG)。此外,对每位患者进行了光学相干断层扫描(OCT)、短波自发荧光成像和低荧光定量分析等影像学研究。
最佳矫正视力范围为20/200至4/200。患者诊断时的中位年龄为23.3岁。大多数患者有畏光和夜盲症状,被归类为菲什曼4期(广泛的脉络膜毛细血管萎缩、斑点吸收和ERG振幅大幅降低)。患者观察到非典型的视网膜色素沉着模式,大多数患者在全视野ERG上表现为锥杆营养不良。OCT对视网膜微观结构的体内评估显示视网膜中央变薄、光感受器不同程度丧失以及三种不同的视网膜结构退化模式。观察到两种不同的异常自发荧光模式。未观察到视网膜退化模式与年龄相关的明显差异。
结果表明,该特定突变与严重的视网膜表型相关,因此可归类为无效突变。对携带特定突变的患者进行仔细的表型分析对于增强我们对与特定突变相关的疾病表达以及由此产生的基因型-表型相关性的理解至关重要。